Selected article for: "immune response and lung infection"

Author: Hartwig, Stacey M.; Holman, Kaitlyn M.; Varga, Steven M.
Title: Depletion of Alveolar Macrophages Ameliorates Virus-Induced Disease following a Pulmonary Coronavirus Infection
  • Cord-id: 4591ewsa
  • Document date: 2014_3_7
  • ID: 4591ewsa
    Snippet: Coronaviruses cause respiratory disease in humans that can range from mild to severe. However, the pathogenesis of pulmonary coronavirus infections is poorly understood. Mouse hepatitis virus type 1 (MHV-1) is a group 2 coronavirus capable of causing severe morbidity and mortality in highly susceptible C3H/HeJ mice. We have previously shown that both CD4 and CD8 T cells play a critical role in mediating MHV-1-induced disease. Here we evaluated the role of alveolar macrophages (AM) in modulating
    Document: Coronaviruses cause respiratory disease in humans that can range from mild to severe. However, the pathogenesis of pulmonary coronavirus infections is poorly understood. Mouse hepatitis virus type 1 (MHV-1) is a group 2 coronavirus capable of causing severe morbidity and mortality in highly susceptible C3H/HeJ mice. We have previously shown that both CD4 and CD8 T cells play a critical role in mediating MHV-1-induced disease. Here we evaluated the role of alveolar macrophages (AM) in modulating the adaptive immune response and subsequent disease. Depletion of AM using clodronate liposomes administered prior to MHV-1 infection was associated with a significant amelioration of MHV-1-induced morbidity and mortality. AM depletion resulted in a decreased number of virus-specific CD4 T cells in the lung airways. In addition, a significant increase in the frequency and total number of Tregs in the lung tissue and lung airways was observed following MHV-1 infection in mice depleted of AM. Our results indicate that AM play a critical role in modulating MHV-1-induced morbidity and mortality.

    Search related documents:
    Co phrase search for related documents
    • activation state and adaptive immune response: 1, 2
    • activation state and lung inflammation: 1
    • acute pulmonary virus infection and adaptive immune response: 1
    • acute respiratory syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and adaptive immune response modulate: 1, 2, 3
    • acute respiratory syndrome and lung airspace: 1, 2, 3
    • acute respiratory syndrome and lung airway: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung depletion: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome and lung function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and lung isolate: 1, 2
    • acute rsv respiratory syncytial virus and adaptive immune response: 1, 2
    • acute rsv respiratory syncytial virus and lung airway: 1, 2
    • acute rsv respiratory syncytial virus and lung depletion: 1
    • acute rsv respiratory syncytial virus and lung inflammation: 1
    • adaptive immune response and lung function: 1, 2, 3, 4
    • adaptive immune response and lung inflammation: 1, 2, 3, 4